Treatment of spasticity in a spinal cord-injured patient with intrathecal morphine due to intrathecal baclofen tolerance - A case report and review of literature

Spinal Cord

Volumn 41, Issue 10, 2003, Pages 586-589

  Soni, B M ^a   Mani, R M ^a   Oo, T ^a   Vaidyanathan, S ^a  

^a SOUTHPORT AND ORMSKIRK HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Intrathecal baclofen; Intrathecal morphine; Spasticity; Tolerance

Indexed keywords

BACLOFEN; MORPHINE;

ADULT; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; DRUG TOLERANCE; HUMAN; MALE; PARAPLEGIA; PRIORITY JOURNAL; SPASTICITY; SPINAL CORD INJURY;

ADULT; BACLOFEN; DRUG TOLERANCE; HUMANS; INFUSION PUMPS, IMPLANTABLE; INJECTIONS, SPINAL; MALE; MORPHINE; MUSCLE RELAXANTS, CENTRAL; MUSCLE SPASTICITY; NARCOTICS; SPINAL CORD INJURIES;

EID: 0141991261     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3101471     Document Type: Article

References (18)

1. Middleton JW et al. Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: a case study. Arch Phys Med Rehabil 1996; 77: 824-826.
2. Soni BM. Management of spasticity - Southport experience. In: Pedotti A, Ferrarin M, Quintern J, Riener R. (eds). Neuroprosthetics from Basic Research to Clinical Applications. Springer-Verlag: Berlin, Hiedelberg 1996, pp 469-479 (printed in Germany ISBN-3-540-61084-7).
3. Ankman MN et al. Intrathecal baclofen: does tolerence occur. Paraplegia 1993; 31: 516-520.
4. Chabal C, Jacobson L, Terman G. Intrathecal fentanyl alleviates spasticity in the presence of tolerance to intrathecal baclofen. Anesthesiology 1992; 76: 312-314.
5. Erickson DL et al. Control of spasticity by implantable continuous flow morphine pump. Neurosurgery 1985; 16: 215-217.
6. Lewis KS. Mueller WM. Intrathecal baclofen for severe spasticity secondary to spinal cord injury. Ann Pharmacother 1993; 27: 767-774.
7. Kroin JS, Bianchi GD, Penn RD. Intrathecal baclofen down-regulates GABA B receptors in the rat substantia gelatinosa. J Neurosurg 1993; 79: 544-549.
8. Penn RD, Kroin JS. Continuous intrathecal baclofen for severe spasticity. Lancet 1985; 2: 125-127.
9. Porter B. A review of intrathecal baclofen in the management of spasticity. Br J Nurs 1997; 6: 253-262.
10. Ivanhoe CB, Tilton AH, Francisco GE. Intrathecal baclofen therapy for spastic hypertonia. Phys Med Rehab Clin North Am 2001; 4: 923-938.
11. Abel NA, Smith RA. Intrathecal baclofen for treatment of intractable spinal spasticity. Arch Phys Med Rehab 1994: 75: 54-58.
12. Burns AS, Meythaler JM. Intrathecal baclofen in tetraplegia of spinal origin: efficacy for upper extremity hypertonia. Spinal Cord 2001; 39: 413-419.
13. Penn RD, Kroin JS. Long-term intrathecal baclofen infusion for treatment of spasticity. J Neurosurg 1987; 66: 181-185.
14. Erickson DL, Lo J, Michaelson M, Lo JN. Control of intractable spasticity with intrathecal morphine sulfate. Neurosurgery 1989; 24: 236-238.
15. Bloomfield S, Hogg J. Oritz O, Gross R. Analysis of breakthrough pain in 50 patients treated with intrathecal morphine infusion therapy. Proceedings of the Meeting of the American Society for Stereotactic and Functional Neurosurgery. Part 1 Marina del Rey, CA, 1995; Stereotact Func Neurosurg 1995; 65: 142-146.
16. Azouvi P et al. Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long term follow-up. Arch Phys Med Rehab 1996; 77: 35-39.
17. Reeves RK, Stolp-smith KA, Christopherson MW. Hyperthermia, rhabdomyolysis and disseminated intravascular coagulation associated with baclofen pump catheter failure. Arch Phvs Med Rehab 1998; 79: 353-356.
18. Levin AB. Sperling KB. Complications associated with infusion pumps implanted for spasticity. Proceedings of the Meeting of the American Society for Stereotactic and Functional Neurosurgery, Part 1: Marina del Rey, CA. 1995: Stereotact Func Neurosurg 1995; 65: 147-151.